HCPCS Code J0588: Injection, Incobotulinumtoxin A, 1 Unit

Learn about the HCPCS code J0588 for injection, incobotulinumtoxin A, 1 unit, through this short guide.

## **What is the HCPCS code J0588 for?** The HCPCS code J0588 is one of the many J codes used to designate injected medication. For this code, what is being designated is the injection of Incobotulinumtoxin A, billed per 1 unit. Incobotulinumtoxin A comes in 50-unit and 100-unit vials, you do not bill per vial; you bill the exact number of units administered. This injection is commonly known as a Xeomin injection. It contains a botulinum toxin treatment that is injected into certain muscles. What muscles, to be exact, will vary depending on the reason why the healthcare provider is using it. Once injected, the medicine will temporarily reduce muscle activity. By reducing muscle activity, the medicine can reduce a patient’s muscle spasms and stiffness. FDA-approved uses include conditions such as cervical dystonia, blepharospasm, upper limb spasticity, and sialorrhea. In some cases, providers may also use it off-label for conditions such as chronic migraine or bladder dysfunction, but these indications are not part of the official Xeomin approval. This injection should only be used when patients have not responded well to more conservative treatments.

## **Documentation requirements for J0588** For those submitting claims for procedure codes involving injections (or any other HCPCS code), you must have comprehensive documentation of the procedure. It's important to document the following before you file for a claim that includes this code: - The full name of the personnel who administered the injection and their credentials - The name and address of the facility where the injection was administered - The full name of the patient - The date and time of the drug administration by injection, as well as the drug manufacturer, and NDC - Patient records showing they have been diagnosed with an approved indication such as cervical dystonia, blepharospasm, upper limb spasticity, or sialorrhea to justify medical necessity. If used off-label (e.g., chronic migraine, bladder issues), documentation should clearly reflect clinical justification and payer-specific approval when applicable. - Relevant detailed medical history - Treatment plans and follow-up plans - The exact dosage (each 1 unit injected is 1 unit billed) - Location of injection (e.g., upper limb muscles because of upper limb spasticity)

## **Billing requirements for J0588** Claims submitted for this must contain the following to avoid the risk of billing problems and claim rejections: - The number of units billed must reflect the dosage given over the course of the treatment. - Use either of two modifiers: JW if there's unused medication/discarded amounts in a vial (wastage), or JZ if there's no unused medication. - For simple therapeutic injections, CPT 96372 may apply. However, most botulinum toxin injections (including Xeomin) are billed with CPT codes 64612–64647, depending on the injection site (e.g., face, limbs, bladder). Providers must match the correct CPT administration code to the injection site and treatment plan. - The relevant ICD-10-CM codes related to the ailment being addressed (e.g., G51.8 - Other disorders of facial nerve; G43.011 - Migraine without aura, intractable, with status migrainosus) If a single dose vial is split between multiple patients, Medicare will allow payment only for the portion used for the beneficiary plus a pro rata amount for wastage. Note that if non-Medicare patients are treated with a portion of the same vial, it would be expected that those non-Medicare patients be billed for their pro rata share of wastage. Ensure that you follow mandates and coding information set by Centers for Medicare/Medicaid Services for billing and coding (especially Medicare Part B criteria), the American Medical Association, etc.

## **Other similar codes** - **J0585** - Injection, onabotulinumtoxina, 1 unit - **J0586** - Injection, abobotulinumtoxina, 5 units - **J0587** - Injection, rimabotulinumtoxinb, 100 units - **J0638** - Injection, canakinumab, 1 mg - **J0584** - Injection, burosumab-twza 1 mg

Frequently asked questions

Usually neurologists, dermatologists, and plastic surgeons.

It depends from patient to patient, but it could take between a couple of days to a couple of weeks.

No. Treatment is ongoing, so there are follow-ups usually 3 to 6 months after each shot depending on the condition, patient response, and medical necessity.